Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | ST14 |
| Gene Name: | ST14 |
| Protein Full Name: | Suppressor of tumorigenicity 14 protein |
| Alias: | Epithin; HAI; Matriptase; Membrane-type serine protease 1; MTSP1; MT-SP1; MTSP-1; Prostamin; PRSS14; Serine protease TADG-15; SNC19; Suppression of tumorigenicity 14 (colon carcinoma); Suppressor of tumorigenicity 14; TADG15; TADG-15; Tumor associated differentially-expressed gene 15 protein |
| Mass (Da): | 94770 |
| Number AA: | 855 |
| UniProt ID: | Q9Y5Y6 |
| Locus ID: | 6768 |
| COSMIC ID: | ST14 |
| Gene location on chromosome: | 11q24.3 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | GAIN |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 19626 |
| Percent of cancer specimens with mutations: | 0.74 |
| Normal role description: | Cleaves and activate hepatocyte growth factor/ scattering factor and urokinase plasminigen activator. |